跳至主要内容
临床试验/2024-515110-40-00
2024-515110-40-00招募中3 期

DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomized, controlled, outcome assessor-blinded, three armed parallel 1:1:1, multicenter trial comparing efficacy and cost effectiveness of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as a short and long term treatment strategy in mild or moderate Dupuytren’s contracture

Pirkanmaan hyvinvointialue, Pirkanmaan hyvinvointialue6 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年9月3日最近更新:
相关药物

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
50
试验地点
6
主要终点
Success at five years

研究概览

简要总结

To determine, which treatment strategy 1) primary PNF followed by surgical LF in patients who do not respond to PNF, 2) primary CCH followed by surgical LF in patients who do not respond to CCH or 3) LF as the primary (and secondary) treatment modality is the most efficacious and cost-effective in treating DC in 5-year follow-up.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • patients with at least 20° combined extension deficit in metacarpophalangeal joint (MP) and/or proximal interphalangeal joint (PIP) in finger/fingers II-V 2) age > 18 years 3) palpable cord 4) provision of informed consent 5) ability to fill the Finnish versions of questionnaires

排除标准

  • recurrent contracture in the finger to be treated 2) neurologic condition causing the loss of function of the finger to be treated 3) contraindication for collagenase clostridium histolyticym (Xiapex/Xiaflex ®) 4) pregnant or breast feeding 5) TPED > 135° (Tubiana stage 472) in finger to be treated 6) rheumatoid arthritis 7) previous fracture in finger to be treated, which affects range of motion of MP or PIP joint 8) age > 80 years

结局指标

主要结局

Success at five years

Success at five years

次要结局

未报告次要终点

研究者

发起方
Pirkanmaan hyvinvointialue, Pirkanmaan hyvinvointialue
申办方类型
Hospital/Clinic/Other health care facility, Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Olli Leppänen

Scientific

Pirkanmaan hyvinvointialue

研究点 (6)

Loading locations...

相似试验